Contrast echocardiography: Putting things into perspective - A Canadian Cardiovascular Society/Canadian Society of Echocardiography joint commentary

Canadian Journal of Cardiology

Volumn 24, Issue 11, 2008, Pages 835-837

  Amyot, Robert ^a   Yu, Eric ^b   Honos, George ^c   Choy, Jonathan ^d   Schnell, Greg ^e   Leong Poi, Howard ^f  

^a Hôpital du Sacr ace Coeur   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^e Foothills General Hospital   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; COMORBIDITY; CONTRAST ECHOCARDIOGRAPHY; CYANOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; EXERCISE TEST; HEART ARREST; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOTENSION; IMAGE ENHANCEMENT; IMAGE QUALITY; LUNG EMBOLISM; MORTALITY; NOTE; PATIENT SAFETY; QUALITATIVE DIAGNOSIS; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; SYSTOLIC DYSFUNCTION; TREADMILL EXERCISE; CANADA; CARDIOVASCULAR DISEASE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; MEDICAL SOCIETY; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

CANADA; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL;

EID: 58149162040     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70191-0     Document Type: Article

References (15)

1. Honos G, Amyot R, Choy J, Leong-Poi H, Schnell G, Yu E. Contrast echocardiography in Canada: Canadian Cardiovascular Society/Canadian Society of Echocardiography position paper. Can J Cardiol 2007;23:351-6.
2. Marwick TH, Nemic JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992;19:74-81.
3. Shaw LJ. Impact of contrast echocardiography on diagnostic algorithms: Pharmaco-economic implications. Clin Cardiol 1997;20(Suppl 1):I39-48.
4. Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardiography: Current and future applications. American Society of Echocardiography Task Force on Standards and Guidelines for the Use of Ultrasonic Contrast in Echocardiography. J Am Soc Echocardiogr 2000;13:331-42.
5. New U.S. Food and Drug Administration prescribing information for Definity, approved October 10, 2007. (Version current at October 1, 2008).
6. Health Canada. drugs and health products: Advisories, warnings, and recalls, October 19, 2007. (Version current at January 27, 2008).
7. Main ML, Goldman JH, Grayburn PA. Thinking outside the "box". The ultrasound contrast controversy. J Am Coll Cardiol 2007;50;2434-7.
8. Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: Results in 18,671 consecutive studies. J Am Coll Cardiol 2008;51:1704-6.
9. Dolan MS, Dodla S, Xie F, Cloutier D, Porter T, Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents in a clinical setting. J Am Coll Cardiol 2008;51(Suppl 1):409-7.
10. Cohen JL, Cheirif J, Segar DS, et al. Improved left ventricular endocardial border delineation and opacification with Optison (FS069), a new echocardiographic contrast agent: Results of a phase III multicenter trial. J Am Coll Cardiol 1998;32:746-52.
11. Klinke WP, Kubac G, Talibi T, Lee SJ. Safety of outpatient catheterization. Am J Cardiol 56:639-41.
12. Noto TJ, Johnson LW, Krone R, et al. Cardiac catheterization 1990: A report of the registry of the society for cardiac angiography and interventions (SCA&I). Cathet Cardiovasc Diagn 91;24:75-83.
13. Seward JB, Khandheria BK, Oh JK, Freeman WK, Tajik AJ. Critical appraisal of transesophageal echocardiography: Limitations, pitfalls, and complications. J Am Soc Echocardiogr 1992;5:288-305.
14. New U.S. Food and Drug Administration prescribing information for Definity, approved April 8, 2008. (Version current at October 1, 2008).
15. Health Canada. Drugs and health products: Advisories, warnings, and recalls. (Version current at October 1, 2008).